Calidi Biotherapeutics Ratios (2021-2025) | CLDI

Ratios Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Efficiency
Assets Average (Quarter) 231.50M231.13M136.59M22.38M22.89M43.59M31.30M14.30M8.71M6.92M6.54M10.42M14.62M12.21M11.69M11.44M
Equity Average (Quarter) -34.62M-38.63M-41.78M-47.18M-52.77M-59.40M-32.40M-4.66M-11.40M-13.16M-10.78M-3.92M4.63M4.69M4.64M5.48M
Invested Capital (Quarter) -31.61M-37.62M-39.64M-43.93M-49.44M-54.96M-63.44M-0.09M-8.23M-14.37M-11.54M-9.58M2.19M7.30M2.08M7.20M3.76M
Leverage & Solvency
Interest Coverage Ratio (Quarter) -240.90-46.88-27.07-31.43-32.3838.97-43.56-34.98-53.33-37.63-148.88-195.31-162.84-893.20
Debt to Equity (Quarter) -0.020.000.00-2.70-0.25-0.01-0.02-0.020.11240.850.040.05
Debt Ratio (Quarter) 0.390.000.010.160.210.030.030.030.0253.470.020.02
Equity Ratio (Quarter) -0.14-0.16-0.17-1.04-19.42-1.28-1.45-0.06-0.82-1.97-1.83-1.470.140.480.220.510.42
Times Interest Earned (Quarter) -240.90-46.88-27.07-31.43-32.3838.97-43.56-34.98-53.33-37.63-148.88-195.31-162.84-893.20
Valuation
Enterprise Value (Quarter) -0.22M-0.22M-0.45M-1.14M-0.84M-1.41M-9.16M-10.24M-4.99M-10.12M-0.22M
Return Ratios
Return on Capital Employed (Quarter) 60.96%-107.24%-66.72%-116.82%-712.16%485.98%481.99%547.57%-2,357.99%-218.40%-291.46%-304.76%-269.58%
Return on Invested Capital (Quarter) 0.00%0.00%0.00%0.01%0.07%0.03%0.02%0.03%0.06%-0.04%-0.04%-0.04%-0.04%
Return on Assets (Quarter) 0.00%0.00%-0.01%-0.01%-0.01%-0.02%-0.03%-0.03%-0.04%-0.02%-0.01%-0.02%-0.02%-0.02%
Return on Equity (Quarter) 0.00%0.00%0.00%0.01%0.01%0.06%0.03%0.02%0.02%0.06%-0.04%-0.04%-0.04%-0.04%